Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms |
Target |
Action inhibitors |
Mechanism GSK-3 inhibitors(Glycogen synthase kinase-3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC51H63N13O12S |
InChIKeyQJSFLEBIQZMJQF-UHFFFAOYSA-N |
CAS Registry2721998-87-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | China | 01 Dec 2021 |